Trial Profile
Comparison of SGLT2 inhibitors versus DPP-4 inhibitors for diabetic macular edema
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2016
Price :
$35
*
At a glance
- Drugs Canagliflozin (Primary) ; Sitagliptin (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 01 Nov 2016 Status changed from recruiting to discontinued.
- 11 Dec 2014 New trial record